Correction to: Good response to tolvaptan shortens hospitalization in patients with congestive heart failure

被引：0
|
作者：
Tomohito Kogure
Kentaro Jujo
Kazuyuki Hamada
Katsumi Saito
Nobuhisa Hagiwara
机构：
[1] Tokyo Women’s Medical University,Department of Cardiology
[2] Nishiarai Heart Center Hospital,Department of Cardiology
来源：
Heart and Vessels | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication of the article, the values of blood urea nitrogen (BUN) and plasma renin activity (PRA) have been published incorrectly and the corrected values are as follows.
引用
收藏
页码：384 / 384
相关论文
共 50 条
  • [21] Ratio of urine and blood urea nitrogen concentration predicts the response of tolvaptan in congestive heart failure
    Shimizu, Keisuke
    Doi, Kent
    Imamura, Teruhiko
    Noiri, Eisei
    Yahagi, Naoki
    Nangaku, Masaomi
    Kinugawa, Koichiro
    NEPHROLOGY, 2015, 20 (06) : 405 - 412
  • [22] Effect of serum sodium concentration and tolvaptan treatment on length of hospitalization in patients with heart failure
    Cyr, Philip L.
    Slawsky, Katherine A.
    Olchanski, Natalia
    Krasa, Holly B.
    Goss, Thomas F.
    Zimmer, Christopher
    Hauptman, Paul J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (04) : 328 - 333
  • [23] Long-term effects of tolvaptan in patients requiring recurrent hospitalization for heart failure
    Ogawa, Hayato
    Ajioka, Masayoshi
    Ishii, Hideki
    Okumura, Takahiro
    Murase, Yosuke
    Osanai, Hiroyuki
    Nakasima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (03): : 355 - 362
  • [24] THE CORRECTION OF HYPONATREMIA IN CONGESTIVE HEART FAILURE
    LUCKEY, EH
    RUBIN, AL
    CIRCULATION, 1960, 21 (02) : 229 - 235
  • [25] Ammonia response to exercise in patients with congestive heart failure
    Ogino, K
    Osaki, S
    Kitamura, H
    Noguchi, N
    Hisatome, I
    Matsumoto, T
    Omodani, H
    Kato, M
    Kinugawa, T
    Miyakoda, H
    Kotake, H
    Mashiba, H
    HEART, 1996, 75 (04) : 343 - 348
  • [26] The Efficacy of Tolvaptan on Renal Function under Reduced Loop Diuretics in Patients with Congestive Heart Failure
    Hanatani, Akihisa
    Yamazaki, Takanori
    Sugioka, Kenichi
    Ehara, Shoichi
    Nakamura, Yasuhiro
    Izumi, Yasukatsu
    Takemoto, Yasuhiko
    Takagi, Masahiko
    Shimada, Kenei
    Yoshiyama, Minoru
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S156 - S156
  • [27] Comparison of two doses and dosing regimens of tolvaptan in congestive heart failure
    Hauptman, PJ
    Zimmer, C
    Udelson, J
    Shoaf, SE
    Mallikaarjun, S
    Bramer, SL
    Orlandi, C
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (05) : 609 - 614
  • [28] The Study of Tolvaptan in 15 Cases of Congestive Heart Failure Patients Despite the Use of Conventional Diuretics
    Takagi, Toshimitsu
    Namura, Masanobu
    Ikeda, Masatoshi
    Horita, Yuuki
    Inoki, Isao
    Sakata, Kennichi
    Terai, Hidenobu
    Tama, Naoto
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S174 - S174
  • [29] Usefulness of the Long-Term Tolvaptan for the Congestive Heart Failure (CHF)
    Iwaki, Taku
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S187 - S187
  • [30] The effect of serum albumin levels on length of hospitalization in patients with congestive heart failure
    Shah, A. R.
    Mirza, A. A.
    Malay, R.
    Sanzaari, L.
    Soucier, R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 140 - 141
12345